22nd Jul 2021 13:29
Ap19
FORM 8.3 Amendment to purchase & sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 20 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,895,838 | 1.47% | 240,370 | 0.19% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 227,408 | 0.18% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,968,197 | 1.53% | 467,778 | 0.36% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 219.2900 USD |
Purchase | 3 | 219.7400 USD |
Purchase | 12 | 220.0100 USD |
Purchase | 70 | 219.7300 USD |
Purchase | 74 | 220.6300 USD |
Purchase | 76 | 217.0200 USD |
Purchase | 89 | 220.0700 USD |
Purchase | 100 | 219.6500 USD |
Purchase | 153 | 219.9738 USD |
Purchase | 169 | 219.8200 USD |
Purchase | 471 | 220.0609 USD |
Purchase | 508 | 220.7668 USD |
Purchase | 1,172 | 219.8629 USD |
Purchase | 1,174 | 218.8054 USD |
Purchase | 1,376 | 219.6985 USD |
Purchase | 1,678 | 219.7523 USD |
Purchase | 2,347 | 219.7476 USD |
Purchase | 2,771 | 219.7636 USD |
Purchase | 3,014 | 219.5013 USD |
Purchase | 4,929 | 219.9123 USD |
Purchase | 5,276 | 219.7000 USD |
Purchase | 11,137 | 219.4594 USD |
Sale | 2 | 219.2900 USD |
Sale | 4 | 220.5662 USD |
Sale | 6 | 219.6900 USD |
Sale | 7 | 220.2285 USD |
Sale | 7 | 219.6985 USD |
Sale | 8 | 219.9218 USD |
Sale | 9 | 220.1900 USD |
Sale | 11 | 220.4400 USD |
Sale | 12 | 220.0100 USD |
Sale | 12 | 220.1845 USD |
Sale | 12 | 220.3791 USD |
Sale | 13 | 220.0326 USD |
Sale | 13 | 220.1761 USD |
Sale | 13 | 220.6107 USD |
Sale | 15 | 219.9386 USD |
Sale | 17 | 220.2423 USD |
Sale | 18 | 220.1066 USD |
Sale | 21 | 219.9142 USD |
Sale | 21 | 219.7492 USD |
Sale | 22 | 218.2927 USD |
Sale | 24 | 219.8600 USD |
Sale | 33 | 220.2190 USD |
Sale | 39 | 219.9539 USD |
Sale | 41 | 220.1254 USD |
Sale | 42 | 220.3371 USD |
Sale | 48 | 219.6989 USD |
Sale | 72 | 220.1333 USD |
Sale | 78 | 219.9603 USD |
Sale | 90 | 220.5784 USD |
Sale | 100 | 219.6800 USD |
Sale | 100 | 219.6500 USD |
Sale | 139 | 219.9085 USD |
Sale | 152 | 217.3229 USD |
Sale | 159 | 220.3520 USD |
Sale | 608 | 220.4318 USD |
Sale | 775 | 219.9480 USD |
Sale | 810 | 218.4034 USD |
Sale | 1,022 | 219.7921 USD |
Sale | 1,319 | 219.7133 USD |
Sale | 1,483 | 219.5771 USD |
Sale | 1,696 | 219.7925 USD |
Sale | 1,837 | 219.7668 USD |
Sale | 2,410 | 219.7028 USD |
Sale | 4,429 | 219.6280 USD |
Sale | 4,697 | 219.7000 USD |
Sale | 14,096 | 219.5723 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 22 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210722005603/en/
Copyright Business Wire 2021
Related Shares:
Barclays